Preservation of renal function by percutaneous transluminal angioplasty inischaemic renal disease

Citation
D. Paulsen et al., Preservation of renal function by percutaneous transluminal angioplasty inischaemic renal disease, NEPH DIAL T, 14(6), 1999, pp. 1454-1461
Citations number
47
Categorie Soggetti
Urology & Nephrology
Journal title
NEPHROLOGY DIALYSIS TRANSPLANTATION
ISSN journal
09310509 → ACNP
Volume
14
Issue
6
Year of publication
1999
Pages
1454 - 1461
Database
ISI
SICI code
0931-0509(199906)14:6<1454:PORFBP>2.0.ZU;2-6
Abstract
Background, The purpose of this study was to evaluate the effects of percut aneous transluminal renal angioplasty (PTRA) on preservation of renal funct ion in patients with bilateral renal artery stenoses or stenosis of the art ery of one functioning kidney. Methods. A total of 227 PTRAs of 223 stenoses in 135 patients were performe d from 1982 to 1993 in a single centre and retrospectively reviewed. The nu mber of PTRAs per patient was 1.7, range 1-6, Angiographical follow-up was performed in 77%, 120 +/- 82 days after the first PTRA and 273 +/- 345 days after the last PTRA. Follow-up of serum creatinine and blood pressure was performed in 85% after 414 +/- 558 days. Long-term follow-up was performed for dialysis, surgical revascularization, renal transplantation and death, mean follow-up 8.8 years, range 5.5-14.8. Results. The immediate technical success was 90%, and another 5% were impro ved. The primary patency rate per patient was 43% and the secondary patency rate 64%. Improved renal function was achieved in 23% of the patients, sta bilized in 56% and failed in 21%. Stabilized or improved function was highe r when baseline serum creatinine was less than or equal to 250 mu mol/l (85 %) than >250 mu mol/l (60%). Three of 99 (3%) patients with creatinine less than or equal to 250 mu mol/l started dialysis during follow-up (41 days, 7.4 and 8 years), as did 13 of 36 (36%) patients with creatinine >250 mu mo l/l. Blood pressure and the number of antihypertensive drugs decreased in p atients with creatinine less than or equal to 250 mu mol/l, but was unchang ed in those with creatinine >250 mu mol/l. The 5-year survival rates were 8 4, 66 and 17% for patients with creatinine <125 mu mol/l, 125-250 mu mol/l and > 250 mu mol/l, respectively. Twelve patients (9%) experienced complica tions, including two deaths. Conclusions. Our study shows that PTRA improved or preserved the renal func tion in most patients with normal to moderately impaired renal function. Cl ose follow-up and possibly re-intervention are necessary to obtain satisfac tory clinical and angiographical result.